Colorectal Cancer Liver Metastases

A Comprehensive Guide to Management
 
 
Springer (Verlag)
  • erschienen am 29. Dezember 2019
 
  • Buch
  • |
  • Hardcover
  • |
  • XVII, 598 Seiten
978-3-030-25485-8 (ISBN)
 

Colorectal cancer is the third most commonly diagnosed condition in oncology, affecting around 1.23 million individuals per year, according to recent statistics. Of these patients, about 50% will develop liver metastases and approximately 20% will present a stage IV disease at diagnosis. These statistics make colorectal liver metastases (CLM) an issue of major importance in current oncology.

The area of CLM is subject to great and continuous advances, as its pathophysiologic mechanisms are better understood and more therapeutic and surgical options are developed. Consequently, all professionals involved with the diagnosis, treatment and follow up of CLM should be kept up to date with the latest advances on the field, to provide high standard medical care to their patients.

This book is designed to present the state-of-the-art in CLM management and, in doing so, to review the current evidence on CLM, discussing all important topics in the field. Coverage is broad and comprehensive, encompassing introductory topics (history, definitions, epidemiology, etc.), basic science subjects (molecular biology, genetics, dissemination process, etc.) and practical clinical topics (tumor behavior, diagnosis, drug therapy, radiation therapy, surgery, ablation, multidisciplinary teams, etc.).

Although comprehensive on the coverage and selection of topics, each chapter is concise and objective, dissecting topics in a practical and direct format. Evidences and recommendations are included. Chapters display a brief introduction of the common knowledge, go straight to the detailed revision of the most recent years of the literature, and end with practical closing observations.

This book is a tool for professionals (general and cancer surgeons, HPB surgeons, clinical oncologists, gastroenterologists and medical residents) and interns who search for a qualified and reader friendly revision on topics concerning Colorectal Cancer Liver Metastases.


1st ed. 2020
  • Englisch
  • Cham
  • |
  • Schweiz
Springer International Publishing
  • Für Beruf und Forschung
  • 67 farbige Abbildungen, 100 farbige Tabellen, 30 s/w Abbildungen
  • |
  • 100 Tables, color; 67 Illustrations, color; 30 Illustrations, black and white; XVII, 598 p. 97 illus., 67 illus. in color.
  • Höhe: 23.5 cm
  • |
  • Breite: 15.5 cm
  • 1363 gr
978-3-030-25485-8 (9783030254858)
10.1007/978-3-030-25486-5
weitere Ausgaben werden ermittelt

Mauro M Correia , MD, PhD: MD from the Federal University of Rio de Janeiro State (Unirio, Brazil, 1984). He completed residencies in general surgery at UFRJ (1987) and in surgical oncology at the National Cancer Institute (Brazil, 1989). Master (1991) and PhD (1997) in general surgery from the Federal University of Rio de Janeiro (UFRJ, Brazil). Oncologic Digestive Endoscopy fellowship at UFF-INCA (1990). Observation HPB Fellow Scholarship at Memorial Sloan Kettering Cancer Center (USA, 1995). Postdoctoral fellowship at Wakefield Clinic (New Zealand, 2004). He coordinated the Medical Residency Program at the National Cancer Institute (Brazil), where he also founded the Liver Group and introduced ablative methods and IOUS. He founded the Brazilian Chapter of the IHPBA. He is a fellow of the Brazilian College of Surgeons, Emeritus President of the Brazilian Chapter of IHPBA and fellow of the Brazilian Society of Surgical Oncology. He has been head of the Surgical Department at UNIGRANRIO University for 18 years. His research has contributed to developing medical educational imaging, navigated liver surgery with augmented reality and epidemiological research on colorectal liver metastases. Dr Correia has coordinated the production of the first Treatise of Oncology in Brazil, gathering 400 national and international collaborators in 2013 and is author to other 10 books and 46 book chapters in Portuguese, Spanish and English in the area of Surgical Oncology (Gastric Cancer; Hepatobiliary Cancer Surgery). He has also written many scientific papers and is member of the editorial board of the REVISTA BRASILEIRA DE CANCEROLOGIA and ACTA SCIENTIAE ANATOMICA.


Michael A Choti , MD: Dr. Choti received his MD degree from Yale University, general surgery training at the University of Pennsylvania, and completed the surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center before joining the division of Surgical Oncology at Johns Hopkins. Among his leadership roles, he was the Chair of Surgery at the University of Texas Southwestern Medical Center. Currently, he is the Chief of Surgery at Banner MD Anderson Cancer Center in Phoenix, Arizona. Dr. Choti is an active clinician and researcher with an interest in new approaches for the treatment of liver and colorectal cancer. He has served on various leadership positions in national and international societies and has chaired study sections for the American Cancer Society. He served as Chair of the NCI-CTEP Hepatobiliary Task Force as well as on the American College of Surgeons' Commission on Cancer, the GI committees of NSABP and ACOSOG, and the Colorectal Cancer Guideline Panel of NCCN. He has directed educational symposia and served on program committees for ASCO, SSO, AACR, among others. He also was a Section Editor for the Annals of Surgical Oncology. Currently, he is on the Surgical Oncology Board for the American Board of Surgery.


Flavio G Rocha , MD: Dr. Rocha is a surgeon in Seattle, Washington and is affiliated with Virginia Mason Medical Center. He received his medical degree from the University of Chicago Pritzker School of Medicine and has been in practice for 20 years. He completed a postdoctoral fellowship in tissue engineering and drug delivery (2003-2006), residency in surgery (2002-2008) and was chief resident in surgery (2008-2009) at Brigham and Women's Hospital, Harvard Medical School (USA) and fellow in surgical oncology (2009-2011) and in hepatopancreatobiliary surgery (2010-2011) at Memorial Sloan Kettering Cancer Center (USA). He is currently a surgeon at Virginia Mason Medical Center.
Go Wakabayashi , MD, PhD, FACS: Dr. Wakabayashi earned his degrees from Keio University School of Medicine (Japan). He trained at the Department of Surgery at Massachusetts General Hospital and Harvard Medical School. After working as an assistant professor at the Department of Surgery, Keio University School of Medicine, he was appointed professor and Chairman of Department of Surgery at Iwate Medical University School of Medicine in 2005. Since April 2015, he has been director of the Center for Advanced Treatment of HPB Disease and Chief of Surgical Services at Ageo Central General Hospital.
1. History of Colorectal Liver Metastases (CLM)2. How and Why does CLM Occur3. Biological Behaviour of CLM4. Diagnostic Workup5. Staging of CLM6. Prognostic Factors7. Clinical Scoring Systems 8. Patient and Treatment Selection9. The impact of Multimodal Team and Strategies10. Evolution of Chemotherapy and Biologicals11. Neoadjuvant12. Conversion13. Adjuvant treatment14. Palliative treatment15. Intra-arterial chemotherapy 16. BEADS - chemoembolization17. Immunotherapy and Vaccines 18. The role of surgery19. Liver first20. Combined resection21. Staged resection22. Resection + ablation23. Special Techniques - PVE , ALLPS, Torsilli, Vascular Reconstruction24. Parenchymal sparing surgery25. Re-resection26. Liver pedicle lymphadenectomy27. Anatomical, Physiological and Kinetic evaluation of the future liver remnant 28. Liver and EHD29. The Issue of Surgical Margins30. Laparoscopic and Robotic Resection31. Navigation and Enhanced reality32. Liver transplantation for CLM 33. Ablative Techniques34. SIRT 35. External Radiation 36. Combined Treatment - MARCELO RIBEIRO 37. Follow Up Strategy38. Prognosis and Management of Recurrence39. Experiences in different continents (LIVERMET SURVEY)
"This book is written for senior residents through junior practicing surgeons. For individuals seeking a resource on this topic, this book is an excellent option. ... This is an excellent resource for colorectal surgeons." (Peter Nau, Doody's Book Reviews, June 19, 2020)
Colorectal cancer is the third most commonly diagnosed condition in oncology, affecting around 1.23 million individuals per year, according to recent statistics. Of these patients, about 50% will develop liver metastases and approximately 20% will present a stage IV disease at diagnosis. These statistics make colorectal liver metastases (CLM) an issue of major importance in current oncology.
The area of CLM is subject to great and continuous advances, as its pathophysiologic mechanisms are better understood and more therapeutic and surgical options are developed. Consequently, all professionals involved with the diagnosis, treatment and follow up of CLM should be kept up to date with the latest advances on the field, to provide high standard medical care to their patients.

This book is designed to present the state-of-the-art in CLM management and, in doing so, to review the current evidence on CLM, discussing all important topics in the field. Coverage is broad and comprehensive, encompassing introductory topics (history, definitions, epidemiology, etc.), basic science subjects (molecular biology, genetics, dissemination process, etc.) and practical clinical topics (tumor behavior, diagnosis, drug therapy, radiation therapy, surgery, ablation, multidisciplinary teams, etc.).

Although comprehensive on the coverage and selection of topics, each chapter is concise and objective, dissecting topics in a practical and direct format. Evidences and recommendations are included. Chapters display a brief introduction of the common knowledge, go straight to the detailed revision of the most recent years of the literature, and end with practical closing observations.

This book is a tool for professionals (general and cancer surgeons, HPB surgeons, clinical oncologists, gastroenterologists and medical residents) and interns who search for a qualified and reader friendly revision on topics concerning Colorectal Cancer Liver Metastases.
DNB DDC Sachgruppen

Versand in 7-9 Tagen

171,19 €
inkl. 5% MwSt.
in den Warenkorb